CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Smoking cessation - Management
Bupropion
- Bupropion has been used as an antidepressant, but it is licensed in the UK for use as an aid to smoking cessation in conjunction with behavioural support. It is a relatively weak but selective inhibitor of the neuronal re-uptake of dopamine and noradrenaline. Although the exact mechanism by which it aids smoking cessation is unclear, it is presumed to work directly on the brain pathways involved in addiction and withdrawal.
© NHS Institute for Innovation and Improvement